Skip to main content
. 2013 Sep 4;15(5):R76. doi: 10.1186/bcr3470

Table 2.

Odds ratios (ORs) and 95% confidence intervals (CIs) for breast cancer risk by tumor subtype associated with BI-RADS-measured mammographic density

 
Number of subjects
Cases versus controls
 
Triple-negatives versus controls
 
Controls
Cases
Model 1 a
Model 2 b
TN cases, n
Model 1
Model 2
      OR (95% CI) OR (95% CI)   OR (95% CI) OR (95% CI)
Almost entirely fat
25
13
1.00 (Referent)
0.48 (0.22, 1.08)
1
1.00 (Referent)
0.17 (0.02, 1.43)
Scattered fibroglandular densities
197
183
2.07 (0.93, 4.59)
1.00 (Referent)
31
5.96 (0.70, 50.64)
1.00 (Referent)
Heterogeneously dense
253
232
2.06 (0.92, 4.60)
1.00 (0.7, 1.35)
40
5.83 (0.68, 50.04)
0.98 (0.5, -1.75)
Extremely dense
53
63
2.45 (0.99, 6.09)
1.19 (0.72, 1.95)
12
7.13 (0.74, 68.90)
1.20 (0.49, 2.90)
 
 
 
Ptrend = 0.24c
 
Ptrend = 0.31
 
 
 
Basal-like versus controls
 
Luminal A versus controls
 
BL cases, n
 
Model 1
Model 2
LA cases, n
Model 1
Model 2
 
 
 
OR (95% CI)
OR (95% CI)
 
OR (95% CI)
OR (95% CI)
Almost entirely fat
1
 
1.00 (Referent)
0.29 (0.03, 2.51)
4
1.00 (Referent)
0.49 (0.15, 1.59)
Scattered fibroglandular densities
19
 
3.45 (0.40, 29.90)
1.00 (Referent)
69
2.03 (0.63, 6.59)
1.00 (Referent)
Heterogeneously dense
22
 
3.03 (0.34, 26.67)
0.88 (0.43, 1.80)
86
2.09 (0.64, 6.79)
1.03 (0.68, 1.56)
Extremely dense
6
 
3.58 (0.34, 37.97)
1.04 (0.34, 3.17)
22
1.98 (0.54, 7.34)
0.98 (0.50, 1.92)
      Ptrend = 0.67   Ptrend = 0.60

aModel 1 is adjusted for age, race, body mass index, menopausal status, family history of breast cancer, age at menarche, use of hormone therapy, and parity and age at first full-term pregnancy combined, where BI-RADS category 1 (almost entirely fat) is the referent group; bModel 2 is adjusted for the same variables as Model 1 but BI-RADS category 2 (scattered fibroglandular densities) is the referent group; cP-value for trend test is based on the likelihood ratio test statistic and is two-sided. The same ordinal model was fit to assess the P-value for trend of Model 1 and Model 2. BI-RADS, Breast Imaging Reporting and Data System; TN, triple-negative; BL, basal-like; LA, luminal-A; n, number of subjects.